1. Home
  2. ELVN vs ALGT Comparison

ELVN vs ALGT Comparison

Compare ELVN & ALGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • ALGT
  • Stock Information
  • Founded
  • ELVN 2016
  • ALGT 1997
  • Country
  • ELVN United States
  • ALGT United States
  • Employees
  • ELVN N/A
  • ALGT N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • ALGT Air Freight/Delivery Services
  • Sector
  • ELVN Health Care
  • ALGT Consumer Discretionary
  • Exchange
  • ELVN Nasdaq
  • ALGT Nasdaq
  • Market Cap
  • ELVN 927.8M
  • ALGT 750.0M
  • IPO Year
  • ELVN 2020
  • ALGT 2006
  • Fundamental
  • Price
  • ELVN $18.42
  • ALGT $54.45
  • Analyst Decision
  • ELVN Strong Buy
  • ALGT Hold
  • Analyst Count
  • ELVN 4
  • ALGT 10
  • Target Price
  • ELVN $39.25
  • ALGT $65.20
  • AVG Volume (30 Days)
  • ELVN 260.6K
  • ALGT 479.3K
  • Earning Date
  • ELVN 05-13-2025
  • ALGT 05-06-2025
  • Dividend Yield
  • ELVN N/A
  • ALGT 1.11%
  • EPS Growth
  • ELVN N/A
  • ALGT N/A
  • EPS
  • ELVN N/A
  • ALGT N/A
  • Revenue
  • ELVN N/A
  • ALGT $2,555,257,000.00
  • Revenue This Year
  • ELVN N/A
  • ALGT $11.20
  • Revenue Next Year
  • ELVN N/A
  • ALGT $10.24
  • P/E Ratio
  • ELVN N/A
  • ALGT N/A
  • Revenue Growth
  • ELVN N/A
  • ALGT 1.54
  • 52 Week Low
  • ELVN $13.30
  • ALGT $36.09
  • 52 Week High
  • ELVN $30.03
  • ALGT $107.57
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 47.86
  • ALGT 59.67
  • Support Level
  • ELVN $17.76
  • ALGT $48.54
  • Resistance Level
  • ELVN $20.79
  • ALGT $55.86
  • Average True Range (ATR)
  • ELVN 1.37
  • ALGT 2.99
  • MACD
  • ELVN 0.12
  • ALGT 1.61
  • Stochastic Oscillator
  • ELVN 45.39
  • ALGT 91.22

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About ALGT Allegiant Travel Company

Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of under-served cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in under-served cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates maximum revenue, and Sunseeker Resort.

Share on Social Networks: